Wednesday, November 2, 2016

uBiome Raises $22M Funding, Launches Gut Biome Testing Service

San Francisco-based uBiome, a developer of a service which uses DNA sequencing to test for the microbiome in the human gut, has raised $22M in a Series B funding, the company disclosed today. The funding was led by 8VC, and also included Slow Ventures, StartX, and angels. The company says it uses 16S rRNA gene sequencing and a custom bioinformatics pipeline to identify dozens of microbial genera and species in the human gut. uBiome says it will use that testing to help patients understand their gut health and health risks. The company is led by Dr. Jessica Richman.